
This article reviews recent therapeutic advances in Alzheimer’s disease
This article reviews recent therapeutic advances in Alzheimer’s disease


Understanding why a colleague is disengaged could make all the difference, Elisabeth Mahese reports
Understanding why a colleague is disengaged could make all the difference, Elisabeth Mahese reports


This investigation explores how an $80 000 a year drug was approved despite concerns
This investigation explores how an $80 000 a year drug was approved despite concerns





1.
2.
3.
4.
5.
6.